Femy stock news.

Find the latest Femasys Inc. (FEMY) stock quote, history, news and other vital information to help you with your stock trading and investing. The company has $10.71 million in cash and $209,098 in debt, giving a net cash position of $10.50 million or $0.66 per share. Cash & Cash Equivalents. 10.71M.What's Happening with FEMY Stock Today. Femasys Inc (FEMY) stock has risen 269.42% while the S&P 500 is down -1.34% as of 1:32 PM on Tuesday, Sep 26. FEMY has gained $0.89 from the previous closing price of $0.33 on volume of 146,410,018 shares. Over the past year the S&P 500 is higher by 17.08% while FEMY is down -0.81%.Femasys (FEMY) stock price is up 1,250% but there are 2 key risks. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-mar... 7 weeks ago - Invezz.FEMY | Complete Femasys Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Sep 26, 2023 · THAR Stock Movement Today. With the name change comes an increased interest in THAR stock on Tuesday. That has more than 12 million shares changing hands as of this writing. To put that in ... High Growth Earnings: FEMY is forecast to remain unprofitable over the next 3 years. Revenue vs Market: FEMY's revenue (64.4% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: FEMY's revenue (64.4% per year) is forecast to grow faster than 20% per year.

3 equities research analysts have issued twelve-month price targets for Femasys' shares. Their FEMY share price targets range from $7.00 to $10.00. On average, they expect the company's stock price to reach $9.00 in the next year. This suggests a possible upside of 884.9% from the stock's current price. View analysts price targets for FEMY or ...ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ...

The latest Femasys stock prices, stock quotes, news, and FEMY history to help you invest and trade smarter. ... Femasys Inc Registered Shs Stock , FEMY. 0.95-0.01 -1.53% ...Zacks Rank: FEMY currently carries a Zacks Rank #3. Femasys Inc. Price and Consensus. Femasys Inc. price-consensus-chart | Femasys Inc. Quote. Stocks to Consider. Here are some stocks in the same ...Femasys Inc. FEMY shares are trading lower Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September.. What To Know: On Sept. 26, shares of the stock surged on news of the FDA clearance for FemaSeed, although the stock pulled back the …Femasys (NASDAQ:FEMY) filed a prospectus related to the offer and resale by the selling stockholders of up to an aggregate of 18.11M shares of common stockThis prospectus is not an offer to sell. ...

High Growth Earnings: FEMY is forecast to remain unprofitable over the next 3 years. Revenue vs Market: FEMY's revenue (64.4% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: FEMY's revenue (64.4% per year) is forecast to grow faster than 20% per year.

AIM ImmunoTech Inc. 0.47. -0.002. -0.4237%. Get Femasys Inc (FEMY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Check if FEMY Stock has a Buy or Sell Evaluation. FEMY Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Femasys Inc. News. Toggle navigation Toggle navigation. ... Chart & Forecast Earnings Insider Trading Signals Historical Prices Predictions News Profile. 3m (119.30%) 12m (-9.54%) Bollinger Bands …Nov. 30, 2023 8:47 AM ET Femasys Inc. (FEMY) By: Sinchita Mitra, SA News Editor. Femasys ( NASDAQ: FEMY )said it has appointed James Liu as its chief medical officer. Shares in the company down 0. ...27 Sep 2023 ... Femasys (NASDAQ: FEMY) stock price has made a strong comeback in the past few days as investors cheer the company's FDA news. The shares surged ...The latest price target for . Femasys (NASDAQ: FEMY) was reported by HC Wainwright & Co. on November 14, 2023.The analyst firm set a price target for $10.00 expecting FEMY to rise to within 12 ...Femasys was founded in 2004 and went public in June 2021 at $13 per share, rising approximately $32M after fees and expenses. The Company then followed …Oct 2, 2023 · On October 2, 2023, FEMY stock experienced significant fluctuations in its performance. The stock had a previous close of $3.01 and opened at $4.59. Throughout the trading day, the stock’s price ranged between $3.30 and $4.75. The volume of shares traded was 1,847,820. FEMY, a company operating in the Electronic Equipment/Instruments industry ... FEMY | Complete Femasys Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

ATLANTA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ...Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.FEMY - Femasys Inc Stock Price and Quote. Nov-23-23 03:38PM. 20 Countries with the Highest Teenage Pregnancy Rates. (Insider Monkey) Nov-15-23 08:30AM. PharmaCyte Biotech Acquires $5 Million Stake in Emerging Womens Health Innovator Femasys, Inc. Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by ... 11/28/2023 - 08:30 AM - Topline results from FemaSeed ® pivotal trial expected in 1H 2024 - - Commercial launch planned for early 2024 - ATLANTA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage ...Femasys saw a decline in short interest in November. As of November 15th, there was short interest totaling 286,700 shares, a decline of 33.0% from the previous total of 427,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will ...High Growth Earnings: FEMY is forecast to remain unprofitable over the next 3 years. Revenue vs Market: FEMY's revenue (64.4% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: FEMY's revenue (64.4% per year) is forecast to grow faster than 20% per year.

The consensus among . 3 Wall Street analysts covering (NASDAQ: FEMY) stock is to Strong Buy FEMY stock. Out of 3 analysts , 2 ( 66.67% ) are recommending FEMY as a Strong Buy, 1 ( 33.33% ) are recommending FEMY as a Buy, 0 ( 0% ) are recommending FEMY as a Hold, 0 ( 0% ) are recommending FEMY as a Sell, and 0 ( 0% ) are recommending FEMY as a ...

FEMY - Femasys Inc Stock Price and Quote. Nov-23-23 03:38PM. 20 Countries with the Highest Teenage Pregnancy Rates. (Insider Monkey) Nov-15-23 08:30AM. PharmaCyte Biotech Acquires $5 Million Stake in Emerging Womens Health Innovator Femasys, Inc. Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by ... 2 Okt 2023 ... Searching for the Perfect Broker? · Learn Stock Trading · Latest News · Before you trade, AskTraders.Femasys (FEMY) Short Interest Ratio and Volume 2023. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. Important info on NVDA trade (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off a Greek island in stormy seas.Femasys was founded in 2004 and went public in June 2021 at $13 per share, rising approximately $32M after fees and expenses. The Company then followed the general market downward for the next two...Discover historical prices for FEMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Femasys Inc. stock was issued.What's Happening with FEMY Stock Today. Femasys Inc (FEMY) stock has risen 269.42% while the S&P 500 is down -1.34% as of 1:32 PM on Tuesday, Sep 26. FEMY has gained $0.89 from the previous closing price of $0.33 on volume of 146,410,018 shares. Over the past year the S&P 500 is higher by 17.08% while FEMY is down -0.81%.Institutional Ownership and Shareholders. Femasys Inc (US:FEMY) has 32 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,650,299 shares.Track Femasys Inc (FEMY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsOct. 10, 2023 8:23 AM ET PD, AKRO, ETNB UROY LGVN FEMY MTEK PEV PRZO By: Deepa Sarvaiya, SA News Editor. Losers: Akero Therapeutics ( AKRO) -59% to present results from Phase 2b SYMMETRY study ...FEMY Femasys Inc Form 8-K - Current report false000133900500013390052023-09-252023-09-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPOR...

Femasys (FEMY) Short Interest Ratio and Volume 2023. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. Important info on NVDA trade (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off a Greek island in stormy seas.

FEMY Femasys Inc Form D - Notice of Exempt Offering of Securities ... Stocks; Commodities; Forex; Cryptocurrency; The Lounge; News. InvestorsHub Newswire; All Company News; iHub Market News; News Scanner; Price and News Alerts; Investorshub Daily; Newsletters; Market Data. Monitor; Level 2; ... My Stocks Activity; Ticker Buzz …

News Femasys Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.98 Market Cap $22.30 M Shares Outstanding 21.65 M Public …RTTNews. Nov. 15, 2023, 08:41 AM. (RTTNews) - PharmaCyte Biotech, Inc. (PMCB) has made a $5 million investment in Femasys, Inc. (FEMY), a biomedical company. Femasys offers a broad portfolio of in ...Wondering where to invest your money? Compare real estate vs. stocks and find the most profitable investment for your financial situation. Compare real estate vs. stocks and find the most profitable investment for your financial situation. ...Take a Trial Today. Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Get Started. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. About FEMY. our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. the pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the ...ATLANTA, July 27, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting women’s unmet needs worldwide by developing a suite of product candidates and products that include minimally invasive, in-office technologies for reproductive health, announced that the United States Patent and …Femasys Inc (NASDAQ: FEMY) shares surged after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a FEMY stock initially gained 150% before settling slightly lower. According to the USPTO website, should the government agency reasonably assess that an applicant is entitled to a patent under the ...FEMY’s Market Performance. Femasys Inc (FEMY) has experienced a 3.06% rise in stock performance for the past week, with a -36.36% drop in the past month, and a 113.56% rise in the past quarter. The volatility ratio for the week is 11.20%, and the volatility levels for the past 30 days are at 13.36% for FEMY.CHRS : 1.5900 (-0.62%) FEMY : 1.2200 (+0.83%) Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade Globe Newswire - Wed Jul 20, 2022. Webinar to be held Thursday, July 28th @ 10:30am EDT... Jul 27, 2023 · InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Shares of biomedical firm Femasys (NASDAQ:FEMY) more than doubled on Thursday.This followed an important intellectual property (IP ...

Take a Trial Today. Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Get Started. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. Dec 1, 2023 · Femasys Inc’s trailing 12-month revenue is $1.1 million with a % profit margin. Year-over-year quarterly sales growth most recently was -33.3%. Analysts expect adjusted earnings to reach $-0.940 per share for the current fiscal year. Femasys Inc does not currently pay a dividend. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Femasys Inc. analyst ratings, historical stock prices, earnings estimates & actuals. FEMY updated stock price target summary.Instagram:https://instagram. what is ground floor investmentuavs forecastjmuixmusic for trading PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq: FEMY) (“Femasys”), a biomedical company ...U.S.: Nasdaq. Add to Watchlist. 0.00. FEMY. Real Time Quote. About Femasys Inc. Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive ... how to get a home loan without tax returnsfidelity low price stock FEMY Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Femasys in the last 3 months. The average price target is $10.67 with a high forecast of $13.00 and a low forecast of $7.00. The average price target represents a 620.95% change from the last price of $1.48. vanguard total bond market index fund etf According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.Find the latest SEC Filings data for Femasys Inc. Common Stock (FEMY) at Nasdaq.com.Fiscal Q3 2023 ended 9/30/23. Get the latest Femasys Inc (FEMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ...